Synaptic density is decreased in patients with depression, detected by positron emission tomography (PET) (90), while BDNF induces dendritic arborization (91) and neurogenesis, which underlies reversal of depressive behavior in animal models after 1-month of SSRIs (92) or tricyclic antidepressants (93). Here, BDNF is linked to depressive symptom measurement.